IPO Advisory · SME IPO
Aurangabad's industrial suppliers often serve both auto and pharma customers to very different standards — and an SME listing tests whether that diversified business is governed as one coherent story.
Aurangabad, on the Delhi-Mumbai industrial corridor, grew as a planned industrial city with a distinctive mix: auto components and pharma sit side by side, often within the same industrial estates and sometimes the same groups. A supplier here may serve automotive OEMs on one standard and pharma customers on another, each with its own quality regime, cycle and concentration. A listing tests whether that diversified, multi-standard business is presented and governed as one coherent story rather than a set of loosely-related lines. Gladwin builds the finance, governance and board a public investor needs around a diversified industrial supplier, while the merchant banker, auditors and counsel handle the regulated work of the issue.
IPO route
SME IPO · BSE SME / NSE Emerge
Best for
profitable promoter-led issuers building their first public-company operating system in Aurangabad, Maharashtra
Typical timeline
Often 9–15 months after priority control gaps are stabilised
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Aurangabad
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
The distinctive challenge for an Aurangabad supplier is coherence. Serving auto OEMs and pharma customers means operating to two different quality regimes, two demand cycles and two customer bases, and a business that has grown opportunistically can end up running these as loosely-related lines. A public investor needs to underwrite one governed business, so the first readiness task is to present the diversified operation as a coherent whole — with a clear view of how each line contributes and how the combined exposure behaves.
Gladwin helps the board bring the auto and pharma lines into one governed story a first-time investor can weigh together.
A diversified Aurangabad supplier's admission case is coherence — presenting auto and pharma lines as one governed business, not loosely-related operations.
Auto and pharma hold suppliers to very different quality regimes, and a listing requires compliance with each evidenced and reconciled to the accounts, because a lapse on either standard can halt supply to that customer base. A supplier straddling both has to show it manages two regimes without either slipping. Concentration is the other combined exposure: dependence across auto OEMs and pharma customers, and the different cycles each follows, should be quantified together so a public investor sees the whole picture.
Gladwin helps the board govern both quality standards and present combined customer and sector concentration as a managed exposure.
A supplier straddling auto and pharma must govern two quality regimes and one combined concentration; both belong in the admission case.
A diversified supplier run on the promoter's operating judgement needs a finance leader who can present the combined economics of the auto and pharma lines, a company secretary for disclosure, and independent directors who understand both sectors well enough to challenge the numbers. Aurangabad's auto, pharma and engineering talent, and the wider Maharashtra market, give Gladwin the pool to build that leadership and governance.
Before filing, the team rehearses a close, a disclosure review and a committee cycle on live data, so a soft auto quarter or a pharma-customer change is explained from records rather than the promoter's read of either market.
A diversified supplier is list-ready when its auto and pharma lines are governed as one business and its quarter is explained from combined records.
Process timeline
What we do
Worked example
Consider an Aurangabad supplier serving auto OEMs and pharma customers from adjacent operations. Both lines are profitable, but the diagnostic finds them run as loosely-related businesses, quality regimes not reconciled to the accounts, and concentration never quantified together. The operations are capable; the coherent, governed evidence a public investor needs is not built.
Gladwin brings the lines into one governed story, evidences both quality regimes, and quantifies combined concentration, installing a finance leader and independent board. After several cycles the supplier presents one diversified, governed business from controlled data, while the merchant banker, auditors and counsel handle the regulated work of the issue.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Manufacturing SME IPO readiness
BSE SME / NSE Emerge
Technology & SaaS SME IPO readiness
BSE SME / NSE Emerge
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingBecause Gladwin runs your SME IPO end to end — not just readiness, and never just paperwork. From helping you appoint the right merchant banker and market maker, to putting the permanent KMPs your board must have in seat (CFO, Company Secretary and Compliance Head), to bringing in the independent directors and covering every interim appointment while you hire, we build the legal, finance and people foundations a all industries issuer needs before it files on the SME platform. Most advisers hand you a checklist and step back. Gladwin is the only IPO consulting firm in India that owns the entire programme across the legal, finance and people side of readiness, coordinates your bankers, auditors and legal counsel as one critical path, and stays with you when the bell rings and through the public-company quarters beyond it.
Aurangabad — India's regional business base — hosts strong issuer candidates, but local presence only becomes investible when the financials, compliance and leadership are IPO-ready. Gladwin tests the fit against your concentration, capex and governance, recommends the route your board can defend, and runs readiness end to end so a Aurangabad business reaches the SME platform (BSE SME / NSE Emerge) able to operate as a listed company.
It comes down to size, track record and the investor base you can credibly reach: the SME platform (BSE SME / NSE Emerge) suits profitable businesses with post-issue paid-up capital up to ₹25 crore that want growth capital and a public-company track record; the Main Board suits larger, institutionally-followed issuers. Gladwin models your paid-up capital, profitability, concentration and the capex the issue must fund, recommends the route your board can defend to a merchant banker, and keeps a clean migration path to the Main Board open.
Financial track record and restated accounts, related-party transactions, customer and revenue concentration, working-capital and cash discipline, regulatory and statutory compliance, and the durability of the growth story under diligence. These are the areas that stall diligence. Gladwin builds the evidence room, assigns an accountable owner to each risk, and — because we run readiness end to end — coordinates your auditors, legal counsel and merchant banker so the story is consistent across the prospectus.
A public-markets CFO, a Company Secretary and compliance function, and independent directors with genuine sector and capital-markets depth to chair the audit and risk committees. Founder-run businesses often lack this bench. Gladwin installs the permanent KMPs, appoints the right independent directors, and bridges interim gaps so the board is credible on day one — not assembled in a hurry for the prospectus.
Usually several months to around two years — driven less by paperwork than by closing real gaps: restating financials, cleaning related-party arrangements, resolving compliance issues, and getting finance, operations and board leadership in place. Gladwin runs it as one time-boxed programme with named owners, so the calendar is set by genuine readiness rather than a rushed filing date.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
An Aurangabad supplier needs an adviser who can present its auto and pharma lines as one governed business, manage two quality regimes and quantify combined concentration — not a set of loosely-related operations a reviewer cannot underwrite together.
Gladwin builds and runs the finance and governance layer across the diversified business, so the promoter keeps serving both sectors while the merchant banker, auditors and counsel handle the regulated work of the issue.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
IPO readiness is where the global firms stop. It is where Gladwin’s scope begins.
The strategy and assurance firms advise on the IPO. Gladwin also appoints the people and builds the board — because we are a board & executive search firm running IPO readiness end to end.
| Capability across the IPO journey | GladwinEnd-to-end | McKinsey | Bain | PwC | Deloitte |
|---|---|---|---|---|---|
| IPO & transaction advisory | Strategy | Strategy | |||
| End-to-end readiness PMO — finance, legal & people, as one owner | — | — | Part | Part | |
| Board readiness & governance build (not just IPO readiness) | Advisory | Advisory | Part | Part | |
| Appointing independent directors | — | — | — | — | |
| Executive search — permanent KMPs (CFO, CS, Compliance Head) | — | — | — | — | |
| Interim leadership appointments, wherever required | — | — | — | — | |
| Coordinating the merchant banker, auditors & legal counsel | — | — | Part | Part | |
| Stays through listing day & the first public-company quarters | — | — | — | — |
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.